Bunzl PLC
05 July 2006
5 July 2006
BUNZL ACQUIRES HEALTHCARE CONSUMABLES DISTRIBUTION
BUSINESS IN THE UK
Bunzl plc, the international distribution and outsourcing Group, today announces
that it has acquired Southern Syringe Services Limited and Universal Hospital
Supplies Limited from John Denman and other members of his family.
The business, which is based in North London, is involved in the sale and
distribution throughout the UK of healthcare related consumables to a variety of
end users including the NHS, private hospitals and nursing homes. The
consolidated revenue in the year ended December 2005 was £182 million and the
gross assets acquired are expected to be approximately £55 million.
Commenting on the acquisition, Michael Roney, Chief Executive of Bunzl, said:
'The acquisition of Southern Syringe significantly expands our position in the
growing healthcare consumables market. This important step broadens our product
offering and customer base and gives us the opportunity to extend our business
in this sector.'
Enquiries:
Bunzl plc Finsbury
Michael Roney, Chief Executive Roland Rudd
Brian May, Finance Director Morgan Bone
Tel: 020 7495 4950 Tel: 020 7251 3801
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.